智雲健康在港交所上市，保持初心，始終以患者為(wèi)中(zhōng)心，緻力于讓數字健康走進千家萬戶 ClouDr Group's listing on the Hong Kong Stock Exchange marks a significant milestone in our journey. We remain true to our original aspiration, steadfastly focusing on patients and committed to bringing digital health into every household.
雙SaaS系統、智雲健康APP、智雲醫(yī)生APP等産(chǎn)品矩陣，形成“醫(yī)患藥付”一站式慢病管理(lǐ)生态，實現自我造血獲得市場認可(kě) The dual SaaS system, ClouDr Mini Program, Dr ClouDr and other product matrices have formed a one-stop chronic disease management ecosystem of "doctors, patients, drug, payment". ClouDr has achieved self-growth and gained market recognition.
合作(zuò)醫(yī)院近1000家，業務(wù)收入實現300%的增長(cháng) Close to 1,000 partner hospitals; 300% growth in revenues Team expanded with many talents from leaders in the medical and internet industries, such as Johnson & Johnson, Kanghong Pharmaceutical, and Alibaba, among others
吸引大批來自強生、康弘藥業、阿裏巴巴等醫(yī)療與互聯網頭部公(gōng)司優秀人才加入
Hangzhou Kangsheng Health Management and Consulting Co., Ltd. founded.
Our mission: Leverage internet technologies to build stronger trust between doctors and patients, make healthcare more efficient and to improve the allocation of medical resources
智雲快藥，智雲藥城助力中(zhōng)小(xiǎo)藥店(diàn)逆勢增長(cháng)；互聯網醫(yī)療服務(wù)拓展線(xiàn)上場景，成為(wèi)國(guó)内最大線(xiàn)上醫(yī)療服務(wù)器；升級智雲醫(yī)療大腦，推出兩個醫(yī)療行業模型-ClouDGPT、ClouD DTx ClouDr Express, the B2B one-stop procurement, and ClouDr Drug City O2O help small and medium-sized pharmacies to grow. The Internet medical service has been expanded to online scenarios such as Meituan, Ali, etc., and the average daily number of consultation services has exceeded 900,000 times, becoming the largest online medical service provider in China. We upgraded our medical brain and launched two medical industry models - ClouD GPT and CIouD DTx.
布局高端智造寶利化制藥品牌重塑，打造科(kē)技(jì )創新(xīn)驅動與數字研發的現代化制藥集團，加強數字化和智能(néng)化技(jì )術競争力 Lay out the brand of Polifarma Pharmaceutical in the high-end intelligent manufacturing sector, create a modern pharmaceutical group driven by scientific and technological innovation and digital research and development, and strengthen the competitiveness of digital and intelligent technologies.
建立了院内院外、線(xiàn)上線(xiàn)下聯合的數字化慢病全生命周期管理(lǐ)的創新(xīn)生态體(tǐ)系，提出“健康中(zhōng)國(guó)2030計劃”，部署線(xiàn)下健康小(xiǎo)站 It has established an innovative ecosystem for the full-life cycle management of chronic diseases, integrating both in-hospital and out-of-hospital, as well as online and offline approaches. It has put forward the "Healthy China 2030 Plan" and deployed health stations.
開拓院外場景，上線(xiàn)藥店(diàn)SaaS系統——智雲問診，年底前已覆蓋3005家，持續拓展慢病生态鏈，全面提升技(jì )術與服務(wù)品質(zhì) Exploring out-of-hospital market and launch the pharmacy SaaS system, "ClouDr Consultation". By the end of the year, we have covered 3,005 pharmacies. We will expand the ecosystem of chronic disease management, aiming to comprehensively enhance technology and service quality.
業務(wù)戰略全面升級，服務(wù)範圍由糖尿病延展至整個慢病領域，同時品牌名(míng)稱升級為(wèi)“智雲健康”，成為(wèi)中(zhōng)國(guó)最大的數字化慢病管理(lǐ)解決方案提供商(shāng) The business strategy has been upgraded. The service scope has been extended from diabetes to the entire chronic disease field. Meanwhile, the brand name has been upgraded to ClouDr Group, which is the largest provider of digital chronic disease management solutions in China.
